Clinical Data (CLDA) Posts Q2 Loss of $0.79, Misses by 9c
Clinical Data, Inc. (NASDAQ: CLDA) reports Q2 loss of $0.79, versus the analyst estimate of ($0.70). Revenue for the quarter was $3.70 million, which compares to the estimate of $3.90 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- ATA, Inc. (ATAI) Misses Q4 EPS by 1c; Guides FY13 Revs Below
- AFC Enterprises, Inc. (AFCE) Tops Q1 EPS by 4c; Raises FY12 Comps Outlook
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
